FDA Warns Maker of Genetic-Testing Kit

The Food and Drug Administration has ordered 23andme, maker of a popular genetic-testing kit, to halt sales of its heavily marketed product, saying the mail-order tests haven’t been proven effective and could dangerously mislead people about their health, the Washington Post reports.